Package 63323-972-10

{"route": ["INTRAVENOUS"], "spl_id": "864bb02f-d50d-4ae2-ad9c-82bb1e9aed2c", "openfda": {"upc": ["0363323972103"], "unii": ["D35FM8T64X"], "rxcui": ["1731077"], "spl_set_id": ["ffee61d1-c1c6-4224-871c-ab7ff6cd01e5"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63323-972-10)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "63323-972-10", "marketing_start_date": "20190905"}], "brand_name": "Fosaprepitant", "product_id": "63323-972_864bb02f-d50d-4ae2-ad9c-82bb1e9aed2c", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "63323-972", "generic_name": "FOSAPREPITANT", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosaprepitant", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "ANDA206197", "marketing_category": "ANDA", "marketing_start_date": "20190905", "listing_expiration_date": "20261231"}